Aspirin Is Beneficial in Hypertensive Patients With Chronic Kidney Disease-Reference-Cited by-同舟云学术

Aspirin Is Beneficial in Hypertensive Patients With Chronic Kidney Disease

Published:2010-09 Issue:12 Volume:56 Page:956-965
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Jardine Meg J.,Ninomiya Toshiharu,Perkovic Vlado,Cass Alan,Turnbull Fiona,Gallagher Martin P.,Zoungas Sophia,Lambers Heerspink Hiddo J.,Chalmers John,Zanchetti Alberto

Funder

National Health and Medical Research Council

National Heart Foundation

European Commission Project InGenious HyperCare

Dutch Kidney Foundation

Foundation for High Blood Pressure Research Council

AstraZeneca

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference43 articles.

1. High prevalence of chronic kidney disease in Thailand;Perkovic;Kidney Int,2008

2. Prevalence of kidney damage in Australian adults: the AusDiab kidney study;Chadban;J Am Soc Nephrol,2003

3. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey;Coresh;Am J Kidney Dis,2003

4. Prevalence of chronic kidney disease in the United States;Coresh;JAMA,2007

5. Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) study;Ruilope;J Am Soc Nephrol,2001

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Continuous aspirin treatment improves cardiovascular events and all-cause mortality in hemodialysis patients with peripheral artery disease;Renal Failure;2024-07-22

2. Examining the impact of aspirin on patients with chronic kidney disease; a systematic review and meta-analysis;Journal of Renal Injury Prevention;2024-06-24

3. A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty Acids;Cardiovascular Drugs and Therapy;2024-02-16

4. Aspirin for the Primary Prevention of Cardiovascular Diseases in Patients with Chronic Kidney Disease: An Updated Meta-analysis;American Journal of Cardiovascular Drugs;2024-02-01

5. Low‐dose aspirin for prevention of cardiovascular mortality in patients with type 2 diabetes and chronic kidney disease: A real‐world nationwide cohort study;Journal of Diabetes Investigation;2023-12-21